Global Glucose Dependent Insulinotropic Receptor Market Insights, Forecast to 2025

2019-02-05 / 3900.00 / Pharma & Healthcare / 111 Pages

Description

The global Glucose Dependent Insulinotropic Receptor market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Glucose Dependent Insulinotropic Receptor market based on company, product type, end user and key regions.

This report studies the global market size of Glucose Dependent Insulinotropic Receptor in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Glucose Dependent Insulinotropic Receptor in these regions.
This research report categorizes the global Glucose Dependent Insulinotropic Receptor market by top players/brands, region, type and end user. This report also studies the global Glucose Dependent Insulinotropic Receptor market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Amgen Inc
Arena Pharmaceuticals Inc
CymaBay Therapeutics Inc
Dong-A Socio Holdings Co Ltd
F. Hoffmann-La Roche Ltd
GlaxoSmithKline Plc
Hyundai Pharmaceutical Co Ltd
Kowa Co Ltd
Merck & Co Inc
Novartis AG
Taisho Pharmaceutical Holdings Co Ltd
Takeda Pharmaceutical Co Ltd
Yuhan Corp

Market size by Product
DA-1241
GSK-2041706
HD-0471042
HD-0471953
HOB-047
MBX-2982
Others
Market size by End User
Type 2 Diabetes
Obesity
Chronic Obstructive Pulmonary Disease (COPD)
Dyslipidemia
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Glucose Dependent Insulinotropic Receptor market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Glucose Dependent Insulinotropic Receptor market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Glucose Dependent Insulinotropic Receptor companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Glucose Dependent Insulinotropic Receptor submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Glucose Dependent Insulinotropic Receptor are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Glucose Dependent Insulinotropic Receptor market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Content

Table of Contents

1 Study Coverage
1.1 Glucose Dependent Insulinotropic Receptor Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Glucose Dependent Insulinotropic Receptor Market Size Growth Rate by Product
1.4.2 DA-1241
1.4.3 GSK-2041706
1.4.4 HD-0471042
1.4.5 HD-0471953
1.4.6 HOB-047
1.4.7 MBX-2982
1.4.8 Others
1.5 Market by End User
1.5.1 Global Glucose Dependent Insulinotropic Receptor Market Size Growth Rate by End User
1.5.2 Type 2 Diabetes
1.5.3 Obesity
1.5.4 Chronic Obstructive Pulmonary Disease (COPD)
1.5.5 Dyslipidemia
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Glucose Dependent Insulinotropic Receptor Market Size
2.1.1 Global Glucose Dependent Insulinotropic Receptor Revenue 2014-2025
2.1.2 Global Glucose Dependent Insulinotropic Receptor Sales 2014-2025
2.2 Glucose Dependent Insulinotropic Receptor Growth Rate by Regions
2.2.1 Global Glucose Dependent Insulinotropic Receptor Sales by Regions
2.2.2 Global Glucose Dependent Insulinotropic Receptor Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Glucose Dependent Insulinotropic Receptor Sales by Manufacturers
3.1.1 Glucose Dependent Insulinotropic Receptor Sales by Manufacturers
3.1.2 Glucose Dependent Insulinotropic Receptor Sales Market Share by Manufacturers
3.1.3 Global Glucose Dependent Insulinotropic Receptor Market Concentration Ratio (CR5 and HHI)
3.2 Glucose Dependent Insulinotropic Receptor Revenue by Manufacturers
3.2.1 Glucose Dependent Insulinotropic Receptor Revenue by Manufacturers (2014-2019)
3.2.2 Glucose Dependent Insulinotropic Receptor Revenue Share by Manufacturers (2014-2019)
3.3 Glucose Dependent Insulinotropic Receptor Price by Manufacturers
3.4 Glucose Dependent Insulinotropic Receptor Manufacturing Base Distribution, Product Types
3.4.1 Glucose Dependent Insulinotropic Receptor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Glucose Dependent Insulinotropic Receptor Product Type
3.4.3 Date of International Manufacturers Enter into Glucose Dependent Insulinotropic Receptor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Glucose Dependent Insulinotropic Receptor Sales by Product
4.2 Global Glucose Dependent Insulinotropic Receptor Revenue by Product
4.3 Glucose Dependent Insulinotropic Receptor Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Glucose Dependent Insulinotropic Receptor Breakdown Data by End User

6 North America
6.1 North America Glucose Dependent Insulinotropic Receptor by Countries
6.1.1 North America Glucose Dependent Insulinotropic Receptor Sales by Countries
6.1.2 North America Glucose Dependent Insulinotropic Receptor Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Glucose Dependent Insulinotropic Receptor by Product
6.3 North America Glucose Dependent Insulinotropic Receptor by End User

7 Europe
7.1 Europe Glucose Dependent Insulinotropic Receptor by Countries
7.1.1 Europe Glucose Dependent Insulinotropic Receptor Sales by Countries
7.1.2 Europe Glucose Dependent Insulinotropic Receptor Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Glucose Dependent Insulinotropic Receptor by Product
7.3 Europe Glucose Dependent Insulinotropic Receptor by End User

8 Asia Pacific
8.1 Asia Pacific Glucose Dependent Insulinotropic Receptor by Countries
8.1.1 Asia Pacific Glucose Dependent Insulinotropic Receptor Sales by Countries
8.1.2 Asia Pacific Glucose Dependent Insulinotropic Receptor Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Glucose Dependent Insulinotropic Receptor by Product
8.3 Asia Pacific Glucose Dependent Insulinotropic Receptor by End User

9 Central & South America
9.1 Central & South America Glucose Dependent Insulinotropic Receptor by Countries
9.1.1 Central & South America Glucose Dependent Insulinotropic Receptor Sales by Countries
9.1.2 Central & South America Glucose Dependent Insulinotropic Receptor Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Glucose Dependent Insulinotropic Receptor by Product
9.3 Central & South America Glucose Dependent Insulinotropic Receptor by End User

10 Middle East and Africa
10.1 Middle East and Africa Glucose Dependent Insulinotropic Receptor by Countries
10.1.1 Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales by Countries
10.1.2 Middle East and Africa Glucose Dependent Insulinotropic Receptor Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Glucose Dependent Insulinotropic Receptor by Product
10.3 Middle East and Africa Glucose Dependent Insulinotropic Receptor by End User

11 Company Profiles
11.1 Amgen Inc
11.1.1 Amgen Inc Company Details
11.1.2 Company Business Overview
11.1.3 Amgen Inc Glucose Dependent Insulinotropic Receptor Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Amgen Inc Glucose Dependent Insulinotropic Receptor Products Offered
11.1.5 Amgen Inc Recent Development
11.2 Arena Pharmaceuticals Inc
11.2.1 Arena Pharmaceuticals Inc Company Details
11.2.2 Company Business Overview
11.2.3 Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Products Offered
11.2.5 Arena Pharmaceuticals Inc Recent Development
11.3 CymaBay Therapeutics Inc
11.3.1 CymaBay Therapeutics Inc Company Details
11.3.2 Company Business Overview
11.3.3 CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Sales, Revenue and Gross Margin (2014-2019)
11.3.4 CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Products Offered
11.3.5 CymaBay Therapeutics Inc Recent Development
11.4 Dong-A Socio Holdings Co Ltd
11.4.1 Dong-A Socio Holdings Co Ltd Company Details
11.4.2 Company Business Overview
11.4.3 Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Products Offered
11.4.5 Dong-A Socio Holdings Co Ltd Recent Development
11.5 F. Hoffmann-La Roche Ltd
11.5.1 F. Hoffmann-La Roche Ltd Company Details
11.5.2 Company Business Overview
11.5.3 F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Sales, Revenue and Gross Margin (2014-2019)
11.5.4 F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Products Offered
11.5.5 F. Hoffmann-La Roche Ltd Recent Development
11.6 GlaxoSmithKline Plc
11.6.1 GlaxoSmithKline Plc Company Details
11.6.2 Company Business Overview
11.6.3 GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Sales, Revenue and Gross Margin (2014-2019)
11.6.4 GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Products Offered
11.6.5 GlaxoSmithKline Plc Recent Development
11.7 Hyundai Pharmaceutical Co Ltd
11.7.1 Hyundai Pharmaceutical Co Ltd Company Details
11.7.2 Company Business Overview
11.7.3 Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Products Offered
11.7.5 Hyundai Pharmaceutical Co Ltd Recent Development
11.8 Kowa Co Ltd
11.8.1 Kowa Co Ltd Company Details
11.8.2 Company Business Overview
11.8.3 Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Products Offered
11.8.5 Kowa Co Ltd Recent Development
11.9 Merck & Co Inc
11.9.1 Merck & Co Inc Company Details
11.9.2 Company Business Overview
11.9.3 Merck & Co Inc Glucose Dependent Insulinotropic Receptor Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Merck & Co Inc Glucose Dependent Insulinotropic Receptor Products Offered
11.9.5 Merck & Co Inc Recent Development
11.10 Novartis AG
11.10.1 Novartis AG Company Details
11.10.2 Company Business Overview
11.10.3 Novartis AG Glucose Dependent Insulinotropic Receptor Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Novartis AG Glucose Dependent Insulinotropic Receptor Products Offered
11.10.5 Novartis AG Recent Development
11.11 Taisho Pharmaceutical Holdings Co Ltd
11.12 Takeda Pharmaceutical Co Ltd
11.13 Yuhan Corp

12 Future Forecast
12.1 Glucose Dependent Insulinotropic Receptor Market Forecast by Regions
12.1.1 Global Glucose Dependent Insulinotropic Receptor Sales Forecast by Regions 2019-2025
12.1.2 Global Glucose Dependent Insulinotropic Receptor Revenue Forecast by Regions 2019-2025
12.2 Glucose Dependent Insulinotropic Receptor Market Forecast by Product
12.2.1 Global Glucose Dependent Insulinotropic Receptor Sales Forecast by Product 2019-2025
12.2.2 Global Glucose Dependent Insulinotropic Receptor Revenue Forecast by Product 2019-2025
12.3 Glucose Dependent Insulinotropic Receptor Market Forecast by End User
12.4 North America Glucose Dependent Insulinotropic Receptor Forecast
12.5 Europe Glucose Dependent Insulinotropic Receptor Forecast
12.6 Asia Pacific Glucose Dependent Insulinotropic Receptor Forecast
12.7 Central & South America Glucose Dependent Insulinotropic Receptor Forecast
12.8 Middle East and Africa Glucose Dependent Insulinotropic Receptor Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Glucose Dependent Insulinotropic Receptor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer


Table of Figures

List of Tables and Figures

Figure Glucose Dependent Insulinotropic Receptor Product Picture
Table Glucose Dependent Insulinotropic Receptor Market Segments
Table Key Manufacturers Glucose Dependent Insulinotropic Receptor Covered
Table Global Glucose Dependent Insulinotropic Receptor Market Size Growth Rate by Product 2019-2025 (K Pcs) & (Million US$)
Figure Global Glucose Dependent Insulinotropic Receptor Sales Market Share by Product 2014-2025
Figure DA-1241 Product Picture
Table Major Manufacturers of DA-1241
Figure GSK-2041706 Product Picture
Table Major Manufacturers of GSK-2041706
Figure HD-0471042 Product Picture
Table Major Manufacturers of HD-0471042
Figure HD-0471953 Product Picture
Table Major Manufacturers of HD-0471953
Figure HOB-047 Product Picture
Table Major Manufacturers of HOB-047
Figure MBX-2982 Product Picture
Table Major Manufacturers of MBX-2982
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Glucose Dependent Insulinotropic Receptor Market Size Growth Rate by End User 2019-2025 (K Pcs)
Figure Type 2 Diabetes
Figure Obesity
Figure Chronic Obstructive Pulmonary Disease (COPD)
Figure Dyslipidemia
Figure Others
Figure Glucose Dependent Insulinotropic Receptor Report Years Considered
Figure Global Glucose Dependent Insulinotropic Receptor Market Size 2014-2025 (Million US$)
Figure Global Glucose Dependent Insulinotropic Receptor Sales 2014-2025 (K Pcs)
Table Global Glucose Dependent Insulinotropic Receptor Market Size by Regions 2014-2019 (K Pcs) & (Million US$)
Table Global Glucose Dependent Insulinotropic Receptor Sales by Regions 2014-2019 (K Pcs)
Table Global Glucose Dependent Insulinotropic Receptor Sales Market Share by Regions 2014-2019
Figure Global Glucose Dependent Insulinotropic Receptor Sales Market Share by Regions 2014-2019
Figure 2018 Global Glucose Dependent Insulinotropic Receptor Sales Market Share by Regions
Table Global Glucose Dependent Insulinotropic Receptor Revenue by Regions 2014-2019 (Million US$)
Table Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Regions 2014-2019
Figure Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Regions 2014-2019
Figure 2018 Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Regions
Table Global Glucose Dependent Insulinotropic Receptor Sales by Manufacturers (2014-2019) (K Pcs)
Table Global Glucose Dependent Insulinotropic Receptor Sales Share by Manufacturers (2014-2019)
Figure Global Glucose Dependent Insulinotropic Receptor Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Glucose Dependent Insulinotropic Receptor Revenue by Manufacturers (2014-2019) (Million USD)
Table Glucose Dependent Insulinotropic Receptor Revenue Share by Manufacturers (2014-2019)
Figure Glucose Dependent Insulinotropic Receptor Value Share by Manufacturers in 2018
Table Key Manufacturers Glucose Dependent Insulinotropic Receptor Price (2014-2019) (USD/Pcs)
Table Glucose Dependent Insulinotropic Receptor Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Glucose Dependent Insulinotropic Receptor Product Type
Table Date of International Manufacturers Enter into Glucose Dependent Insulinotropic Receptor Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Glucose Dependent Insulinotropic Receptor Sales by Product (2014-2019) (K Pcs)
Table Global Glucose Dependent Insulinotropic Receptor Sales Share by Product (2014-2019)
Figure Global Glucose Dependent Insulinotropic Receptor Sales Market Share by Product (2014-2019)
Figure Global Glucose Dependent Insulinotropic Receptor Sales Market Share by Product in 2018
Table Global Glucose Dependent Insulinotropic Receptor Revenue by Product (2014-2019) (Million US$)
Table Global Glucose Dependent Insulinotropic Receptor Revenue Share by Product (2014-2019)
Figure Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Product (2014-2019)
Figure Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Product in 2018
Table Glucose Dependent Insulinotropic Receptor Price by Product 2014-2019 (USD/Pcs)
Table Global Glucose Dependent Insulinotropic Receptor Sales by End User (2014-2019) (K Pcs)
Table Global Glucose Dependent Insulinotropic Receptor Sales Share by End User (2014-2019)
Figure Global Sales Glucose Dependent Insulinotropic Receptor Market Share by End User (2014-2019)
Figure Global Sales Glucose Dependent Insulinotropic Receptor Market Share by End User in 2018
Figure North America Glucose Dependent Insulinotropic Receptor Sales Growth Rate 2014-2019 (K Pcs)
Figure North America Glucose Dependent Insulinotropic Receptor Revenue Growth Rate 2014-2019 (Million US$)
Table North America Glucose Dependent Insulinotropic Receptor Sales by Countries (2014-2019) (K Pcs)
Table North America Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries (2014-2019)
Figure 2018 North America Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries
Table North America Glucose Dependent Insulinotropic Receptor Revenue by Countries (2014-2019) (Million US$)
Table North America Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries
Figure United States Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure United States Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (K Pcs)
Figure Canada Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure Canada Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure Mexico Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Table North America Glucose Dependent Insulinotropic Receptor Sales by Product (2014-2019) (K Pcs)
Table North America Glucose Dependent Insulinotropic Receptor Sales Market Share by Product (2014-2019)
Figure 2018 North America Glucose Dependent Insulinotropic Receptor Market Share by Product
Table North America Glucose Dependent Insulinotropic Receptor Sales by End User (2014-2019) (K Pcs)
Table North America Glucose Dependent Insulinotropic Receptor Sales Market Share by End User (2014-2019)
Figure 2018 North America Glucose Dependent Insulinotropic Receptor Market Share by End User
Figure Europe Glucose Dependent Insulinotropic Receptor Sales Growth Rate 2014-2019 (K Pcs)
Figure Europe Glucose Dependent Insulinotropic Receptor Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Glucose Dependent Insulinotropic Receptor Sales by Countries (2014-2019) (K Pcs)
Table Europe Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries
Table Europe Glucose Dependent Insulinotropic Receptor Revenue by Countries (2014-2019) (Million US$)
Table Europe Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries
Figure Germany Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure Germany Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Figure France Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure France Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure UK Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure Italy Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure Russia Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Glucose Dependent Insulinotropic Receptor Sales by Product (2014-2019) (K Pcs)
Table Europe Glucose Dependent Insulinotropic Receptor Sales Market Share by Product (2014-2019)
Figure 2018 Europe Glucose Dependent Insulinotropic Receptor Market Share by Product
Table Europe Glucose Dependent Insulinotropic Receptor Sales by End User (2014-2019) (K Pcs)
Table Europe Glucose Dependent Insulinotropic Receptor Sales Market Share by End User (2014-2019)
Figure 2018 Europe Glucose Dependent Insulinotropic Receptor Market Share by End User
Figure Asia Pacific Glucose Dependent Insulinotropic Receptor Sales Growth Rate 2014-2019 (K Pcs)
Figure Asia Pacific Glucose Dependent Insulinotropic Receptor Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Glucose Dependent Insulinotropic Receptor Sales by Countries (2014-2019) (K Pcs)
Table Asia Pacific Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries
Table Asia Pacific Glucose Dependent Insulinotropic Receptor Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries
Figure China Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure China Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure Japan Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure Korea Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Figure India Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure India Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure Australia Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure Indonesia Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure Malaysia Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure Philippines Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure Thailand Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure Vietnam Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure Singapore Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Glucose Dependent Insulinotropic Receptor Sales by Product (2014-2019) (K Pcs)
Table Asia Pacific Glucose Dependent Insulinotropic Receptor Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Glucose Dependent Insulinotropic Receptor Market Share by Product
Table Asia Pacific Glucose Dependent Insulinotropic Receptor Sales by End User (2014-2019) (K Pcs)
Table Asia Pacific Glucose Dependent Insulinotropic Receptor Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Glucose Dependent Insulinotropic Receptor Market Share by End User
Figure Central & South America Glucose Dependent Insulinotropic Receptor Sales Growth Rate 2014-2019 (K Pcs)
Figure Central & South America Glucose Dependent Insulinotropic Receptor Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Glucose Dependent Insulinotropic Receptor Sales by Countries (2014-2019) (K Pcs)
Table Central & South America Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries
Table Central & South America Glucose Dependent Insulinotropic Receptor Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries
Figure Brazil Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure Brazil Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure Argentina Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Glucose Dependent Insulinotropic Receptor Sales by Product (2014-2019) (K Pcs)
Table Central & South America Glucose Dependent Insulinotropic Receptor Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Glucose Dependent Insulinotropic Receptor Market Share by Product
Table Central & South America Glucose Dependent Insulinotropic Receptor Sales by End User (2014-2019) (K Pcs)
Table Central & South America Glucose Dependent Insulinotropic Receptor Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Glucose Dependent Insulinotropic Receptor Market Share by End User
Figure Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales Growth Rate 2014-2019 (K Pcs)
Figure Middle East and Africa Glucose Dependent Insulinotropic Receptor Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales by Countries (2014-2019) (K Pcs)
Table Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales Market Share by Countries
Table Middle East and Africa Glucose Dependent Insulinotropic Receptor Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Glucose Dependent Insulinotropic Receptor Revenue Market Share by Countries
Figure GCC Countries Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure GCC Countries Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure Turkey Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure Egypt Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Glucose Dependent Insulinotropic Receptor Sales Growth Rate (2014-2019) (K Pcs)
Figure South Africa Glucose Dependent Insulinotropic Receptor Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales by Product (2014-2019) (K Pcs)
Table Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Glucose Dependent Insulinotropic Receptor Market Share by Product
Table Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales by End User (2014-2019) (K Pcs)
Table Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Glucose Dependent Insulinotropic Receptor Market Share by End User
Table Amgen Inc Company Details
Table Amgen Inc Glucose Dependent Insulinotropic Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Amgen Inc Recent Development

Table Arena Pharmaceuticals Inc Company Details
Table Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Arena Pharmaceuticals Inc Recent Development

Table CymaBay Therapeutics Inc Company Details
Table CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table CymaBay Therapeutics Inc Recent Development

Table Dong-A Socio Holdings Co Ltd Company Details
Table Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Dong-A Socio Holdings Co Ltd Recent Development

Table F. Hoffmann-La Roche Ltd Company Details
Table F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Ltd Recent Development

Table GlaxoSmithKline Plc Company Details
Table GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table GlaxoSmithKline Plc Recent Development

Table Hyundai Pharmaceutical Co Ltd Company Details
Table Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Hyundai Pharmaceutical Co Ltd Recent Development

Table Kowa Co Ltd Company Details
Table Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Kowa Co Ltd Recent Development

Table Merck & Co Inc Company Details
Table Merck & Co Inc Glucose Dependent Insulinotropic Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck & Co Inc Recent Development

Table Novartis AG Company Details
Table Novartis AG Glucose Dependent Insulinotropic Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis AG Recent Development

Table Taisho Pharmaceutical Holdings Co Ltd Company Details
Table Takeda Pharmaceutical Co Ltd Company Details
Table Yuhan Corp Company Details
Table Global Glucose Dependent Insulinotropic Receptor Sales Forecast by Regions 2019-2025 (K Pcs)
Table Global Glucose Dependent Insulinotropic Receptor Sales Market Share Forecast by Regions 2019-2025
Table Global Glucose Dependent Insulinotropic Receptor Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Glucose Dependent Insulinotropic Receptor Revenue Market Share Forecast by Regions 2019-2025
Table Global Glucose Dependent Insulinotropic Receptor Sales Forecast by Product 2019-2025 (K Pcs)
Table Global Glucose Dependent Insulinotropic Receptor Sales Market Share Forecast by Product 2019-2025
Table Global Glucose Dependent Insulinotropic Receptor Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Glucose Dependent Insulinotropic Receptor Revenue Market Share Forecast by Product 2019-2025
Table Global Glucose Dependent Insulinotropic Receptor Sales Forecast by End User 2019-2025 (K Pcs)
Table Global Glucose Dependent Insulinotropic Receptor Sales Market Share Forecast by End User 2019-2025
Figure North America Glucose Dependent Insulinotropic Receptor Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure North America Glucose Dependent Insulinotropic Receptor Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Glucose Dependent Insulinotropic Receptor Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Europe Glucose Dependent Insulinotropic Receptor Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Glucose Dependent Insulinotropic Receptor Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Asia Pacific Glucose Dependent Insulinotropic Receptor Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Glucose Dependent Insulinotropic Receptor Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Central & South America Glucose Dependent Insulinotropic Receptor Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Glucose Dependent Insulinotropic Receptor Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Middle East and Africa Glucose Dependent Insulinotropic Receptor Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Glucose Dependent Insulinotropic Receptor Value Chain
Table Glucose Dependent Insulinotropic Receptor Customers List
Table Glucose Dependent Insulinotropic Receptor Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Request Sample

* mark fields are compulsory